Lunai Bioworks Inc. current report, 14 March 2022

Business Context and Reporting Period

This Form 8-K reports on the annual meeting of stockholders held by Enochian Biosciences Inc. (Note: The input metadata lists "Lunai Bioworks Inc.", but the filing text explicitly identifies the registrant as Enochian Biosciences Inc.) on March 14, 2022. The company is a Delaware corporation with its principal executive offices in Los Angeles, CA, and its common stock trades on The Nasdaq Stock Market LLC under the symbol ENOB.

Key Financial Metrics

This filing is a Current Report regarding corporate governance events and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.

Material Changes and Voting Results

The filing details the results of two proposals submitted to stockholders:

  • Proposal No. 1: Election of Directors. Stockholders elected eight directors for terms until the next annual meeting. All nominees received significant support, though some faced varying levels of withheld votes:
    • René Sindlev: 31,582,150 votes for; 194,164 withheld.
    • Dr. Mark R. Dybul: 31,582,170 votes for; 194,144 withheld.
    • Dr. Carol L. Brosgart: 31,762,594 votes for; 13,720 withheld.
    • Gregg Alton: 31,133,861 votes for; 642,453 withheld.
    • James Sapirstein: 31,133,801 votes for; 642,513 withheld.
    • Carl Sandler: 31,358,864 votes for; 417,450 withheld.
    • Henrik Gronfeldt-Sorensen: 31,573,117 votes for; 203,197 withheld.
    • Jayne McNicol: 31,763,193 votes for; 13,121 withheld.
  • Proposal No. 2: Ratification of Independent Auditor. Stockholders ratified Sadler, Gibb & Associates, LLC as the independent registered public accounting firm.
    • Votes For: 33,824,502
    • Votes Against: 3,921
    • Abstentions: 27,585

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a disclosure of voting outcomes.

Important Facts for Investors to Verify

  • Confirm the correct registrant name is Enochian Biosciences Inc. (ENOB), not Lunai Bioworks Inc.
  • Verify the specific vote counts for directors Gregg Alton and James Sapirstein, who received the highest number of withheld votes among the nominees.
  • Note that the independent auditor, Sadler, Gibb & Associates, LLC, was ratified with overwhelming support (over 99% of votes cast).
  • Check subsequent filings (e.g., 10-K or 10-Q) for financial performance data, as this 8-K contains no financial metrics.